Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Vrenken

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Neurology|May 3, 2013
Metabolite changes in radiologically isolated syndrome: more pathology than meets the eye?Darin T Okuda, Hugo Vrenken
Expert Review of Neurotherapeutics|March 8, 2007
Gray and normal-appearing white matter in multiple sclerosis: an MRI perspectiveHugo Vrenken, Jeroen J G Geurts
Neurology|August 27, 2010
Toward understanding cortical lesions in multiple sclerosisJeroen J G Geurts, Hugo Vrenken
Magma (New York, N.Y.)|December 13, 2016
Reproducible segmentation of white matter hyperintensities using a new statistical definitionSoheil Damangir, Eric Westman, Andrew Simmons, et al.
Plos One|February 10, 2017
Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentationsFabian Bartel, Hugo Vrenken, Fetsje Bijma, et al.
Journal of Diabetes and Its Complications|January 29, 2013
Dysglycemia, brain volume and vascular lesions on MRI in a memory clinic populationLieza G Exalto, Wiesje M van der Flier, Philip Scheltens, et al.
Neuroimage. Clinical|January 22, 2019
Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRIHoushang Amiri, Iman Brouwer, Joost P A Kuijer, et al.
Multiple Sclerosis and Related Disorders|June 24, 2014
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variablesSimona Vuletic, Hal Kennedy, John J Albers, et al.
Neurobiology of Aging|April 9, 2013
Different patterns of gray matter atrophy in early- and late-onset Alzheimer's diseaseChristiane Möller, Hugo Vrenken, Lize Jiskoot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2015
High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosisMartijn D Steenwijk, Hugo Vrenken, Laura E Jonkman, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Neurology|May 3, 2013
Metabolite changes in radiologically isolated syndrome: more pathology than meets the eye?Darin T Okuda, Hugo Vrenken
Expert Review of Neurotherapeutics|March 8, 2007
Gray and normal-appearing white matter in multiple sclerosis: an MRI perspectiveHugo Vrenken, Jeroen J G Geurts
Neurology|August 27, 2010
Toward understanding cortical lesions in multiple sclerosisJeroen J G Geurts, Hugo Vrenken
Magma (New York, N.Y.)|December 13, 2016
Reproducible segmentation of white matter hyperintensities using a new statistical definitionSoheil Damangir, Eric Westman, Andrew Simmons, et al.
Plos One|February 10, 2017
Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentationsFabian Bartel, Hugo Vrenken, Fetsje Bijma, et al.
Journal of Diabetes and Its Complications|January 29, 2013
Dysglycemia, brain volume and vascular lesions on MRI in a memory clinic populationLieza G Exalto, Wiesje M van der Flier, Philip Scheltens, et al.
Neuroimage. Clinical|January 22, 2019
Novel imaging phantom for accurate and robust measurement of brain atrophy rates using clinical MRIHoushang Amiri, Iman Brouwer, Joost P A Kuijer, et al.
Multiple Sclerosis and Related Disorders|June 24, 2014
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variablesSimona Vuletic, Hal Kennedy, John J Albers, et al.
Neurobiology of Aging|April 9, 2013
Different patterns of gray matter atrophy in early- and late-onset Alzheimer's diseaseChristiane Möller, Hugo Vrenken, Lize Jiskoot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2015
High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosisMartijn D Steenwijk, Hugo Vrenken, Laura E Jonkman, et al.
Pageof 15